Aura Biosciences, Inc.
AURANasdaqCIK 1501796HealthcareFiscal year ends Dec 31
Reports and events: 87 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1107:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-343429 |
| 2026-08-1107:05 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-343408 |
| 2026-08-0516:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-335157 |
| 2026-07-0807:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-297992 |
| 2026-06-2917:28 ET | DEF 14A | Proxy statementPeriod 2026-08-05 | 0001193125-26-288498 |
| 2026-06-1116:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-267676 |
| 2026-05-1116:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-216808 |
| 2026-05-1116:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950142-26-001345 |
| 2026-05-1116:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-216743 |
| 2026-05-0517:21 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-206804 |
| 2026-05-0416:20 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events | 0001193125-26-204049 |
| 2026-05-0406:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-202414 |
| 2026-04-2016:05 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001193125-26-163933 |
| 2026-03-3007:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-130401 |
| 2026-03-3007:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-130383 |
| 2025-11-1307:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-278817 |
| 2025-11-1307:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-278810 |
| 2025-08-1307:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-179426 |
| 2025-08-1307:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-179418 |
| 2025-06-1816:06 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-087885 |
| 2025-05-1916:35 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-002479 |
| 2025-05-1616:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-121677 |
| 2025-05-1506:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071907 |
| 2025-05-1506:02 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-071839 |
| 2025-04-2416:15 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0000950170-25-058062 |
| 2025-04-0207:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-048880 |
| 2025-03-2417:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-043943 |
| 2025-03-2416:01 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-043809 |
| 2024-11-1216:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125428 |
| 2024-11-1216:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-125390 |
| 2024-10-1717:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-238959 |
| 2024-09-2716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-227950 |
| 2024-09-1206:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-217619 |
| 2024-08-0807:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093308 |
| 2024-08-0807:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-093298 |
| 2024-06-2116:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-165656 |
| 2024-06-1416:37 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001193125-24-161680 |
| 2024-06-0417:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-154364 |
| 2024-05-0907:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056265 |
| 2024-05-0907:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056252 |
| 2024-04-2516:05 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001193125-24-113878 |
| 2024-04-1516:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-096204 |
| 2024-03-2707:11 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-036814 |
| 2024-03-2707:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-036811 |
| 2024-01-0807:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-003887 |
| 2023-11-0916:34 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-23-005428 |
| 2023-11-0916:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062097 |
| 2023-11-0916:15 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062074 |
| 2023-11-0616:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-271351 |
| 2023-10-0216:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-249055 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:26 ET. Listed shows no prices and gives no investment advice.